Moreover, breast cancers from patients with aggressive subtypes (i.e., TNBC and HER2+) expressed higher levels of MXRA8 protein in primary tumors and metastatic lesions compared to less aggressive, ER+ breast cancers. The gene discussed is MXRA8; the disease is breast carcinoma.